Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - Findings from the irbesartan in heart failure with preserved Systolic function trial (I-Preserve) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • McMurray, John J
  • Komajda, Michel
  • McKelvie, Robert
  • Zile, Michael
  • Ptaszynska, Agata
  • Massie, Barry M
  • Carson, Peter E

publication date

  • October 16, 2007